Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Amgen inc. save search
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SWTX | $43.96 2.5% 2.43% 870K
|
Health Technology
|
| O: -1.58%
H: 11.22%
C: 11.16%
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: 0.36%
H: 3.65%
C: 3.35%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.5%
H: 3.18%
C: 3.12%
conference therapeutics
Poseida Therapeutics Appoints Rafael G. Amado, M.D., to Board of Directors
Published: 2023-04-13 (Crawled : 14:00) - biospace.com/
PSTX | $2.15 -0.23% -0.23% 420K
|
Health Technology
|
| O: 2.43%
H: 1.58%
C: -4.74%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.36%
H: 1.33%
C: 1.14%
ALLO | $3.365 -1.03% -1.04% 1.6M
|
Health Technology
|
| O: 1.31%
H: 12.04%
C: 8.6%
therapeutics
Efficacy Of Repatha® (Evolocumab) Across High-Risk Patient Populations Reinforced At ACC.21
Published: 2021-05-11 (Crawled : 20:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: -1.96%
H: 8.74%
C: 8.28%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.21%
H: 1.11%
C: -0.34%
risk
Bispecific Antibodies for Cancer Market will Register 6.44% YOY Growth in 2022 | 39% Growth to Originate from North America| 17,000+ Technavio Reports
Published: 2022-03-09 (Crawled : 08:00) - prnewswire.com
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -2.55%
H: 1.28%
C: 0.19%
FSTX | $7.12 0.0% 0
|
Health Technology
|
| O: 8.24%
H: 1.25%
C: -1.99%
MRUS | $40.75 0.74% 0.74% 570K
|
Health Technology
|
| O: 0.5%
H: 5.19%
C: 4.84%
MREO | $2.79 0.0% 790K
|
Health Technology
|
| O: 16.67%
H: 4.76%
C: -0.68%
APVO | $0.7475 5.28% 5.02% 350K
|
Health Technology
|
| O: -2.6%
H: 10.68%
C: 4.31%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.81%
H: 0.13%
C: -1.18%
AFMD | $5.22 4.4% 4.21% 22K
|
Health Technology
|
| O: 2.39%
H: 7.24%
C: 6.07%
america origin report cancer growth antibody
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.11%
H: 0.39%
C: 0.06%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.46%
H: 1.46%
C: 1.15%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -0.33%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.16%
H: 1.21%
C: 0.95%
SUPN | $29.98 0.91% 0.9% 200K
|
Health Technology
|
| O: -0.32%
H: 5.23%
C: 4.43%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.5%
C: 0.41%
OTIC | $0.077
|
Health Technology
|
| O: -1.88%
H: 2.3%
C: 0.0%
OMER | $3.08 0.0% 210K
|
Health Technology
|
| O: -1.44%
H: 3.5%
C: 2.24%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.67%
H: 0.15%
C: -1.22%
BMRN | $92.06 2.87% 2.79% 1.3M
|
Health Technology
|
| O: -0.72%
H: 1.06%
C: 0.76%
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: -4.08%
H: 7.03%
C: 6.04%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.64%
H: 0.2%
C: -0.32%
AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Published: 2023-10-20 (Crawled : 12:00) - prnewswire.com
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: -1.33%
H: 5.87%
C: 5.53%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.64%
lung cancer cell
Global Lupus Therapeutic Market to Surpass US$ 5,408.1 Million by 2030, Says Coherent Market Insights
Published: 2022-03-16 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -0.46%
H: 3.49%
C: 3.49%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
|
| O: 1.41%
H: 2.33%
C: 0.04%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: 2.07%
H: 1.62%
C: 1.56%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.26%
H: 0.31%
C: -0.39%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
AUPH | $5.085 0.69% 0.59% 920K
|
Health Technology
|
| O: 0.95%
H: 6.23%
C: 5.19%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -0.37%
lupus market
111, Inc. Enters into First-Ever Strategic Partnership with BeiGene
Published: 2021-03-17 (Crawled : 12:00) - biospace.com/
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.0%
H: 2.33%
C: 1.65%
YI | $1.08 1.89% 1.85% 25K
|
Retail Trade
|
| O: -4.12%
H: 6.86%
C: 5.0%
partnership
Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
Published: 2021-12-01 (Crawled : 22:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.62%
H: 0.0%
C: 0.0%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 1.59%
H: 13.12%
C: 5.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.78%
H: 2.59%
C: 0.18%
Entera Bio Selected for Late Breaking Oral Presentation of Phase 2 6-Month Osteoporosis Data at ASBMR 2021 Annual Meeting
Published: 2021-09-01 (Crawled : 13:00) - globenewswire.com
ENTX | $2.22 8.29% 7.66% 110K
|
Health Technology
|
| O: 0.82%
H: 5.26%
C: 4.88%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.01%
H: 0.25%
C: -0.98%
presentation phase 2 osteoporosis eb613
MOLN DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - MOLN
Published: 2022-09-07 (Crawled : 06:00) - prnewswire.com
MOLN | $3.88 -3.54% 520
|
Professional, Scientific, and T...
|
| O: 1.61%
H: 2.81%
C: 0.18%
TWTR | $53.7 0.3%
|
Technology Services
|
| O: 1.73%
H: 4.96%
C: 4.83%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.24%
H: 1.04%
C: 0.82%
molecular deadline
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.18%
H: 1.54%
C: 1.39%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.25%
H: 2.13%
C: 1.63%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.21%
H: 0.83%
C: 0.33%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.5%
H: 1.37%
C: 0.91%
XERS | $1.78 0.0% 1.3M
|
Health Technology
|
| O: 0.24%
H: 0.73%
C: -4.13%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.17%
C: -0.13%
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.98%
C: -1.33%
OMER | $3.08 0.0% 210K
|
Health Technology
|
| O: 1.39%
H: 0.79%
C: 0.33%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: 0.57%
H: 0.86%
C: 0.54%
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: 0.5%
H: 4.88%
C: 4.7%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.4%
H: 0.53%
C: 0.25%
AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit
Published: 2023-04-10 (Crawled : 17:00) - prnewswire.com
KRNT | $15.87 1.15% 1.13% 130K
|
Producer Manufacturing
|
| O: -0.79%
H: 2.51%
C: 2.28%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: -2.16%
ALCO | News | $28.08 0.79% 0.78% 9.2K
|
Process Industries
|
| O: -0.63%
H: 4.82%
C: 4.65%
ALCO Investors Have Opportunity to Lead Alico, Inc. Securities Fraud Lawsuit
Published: 2023-04-10 (Crawled : 17:00) - prnewswire.com
KRNT | $15.87 1.15% 1.13% 130K
|
Producer Manufacturing
|
| O: -0.79%
H: 2.51%
C: 2.28%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 1.23%
H: 0.0%
C: -2.16%
ALCO | News | $28.08 0.79% 0.78% 9.2K
|
Process Industries
|
| O: -0.63%
H: 4.82%
C: 4.65%
Amgen Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK 101 Study In Patients With KRAS G12C-mutated Cancers At AACR-NCI-EORTC 2021
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K
|
Health Technology
|
| O: 1.77%
H: 4.53%
C: 4.35%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.69%
H: 1.88%
C: 0.28%
phase 1 cancer phase 1b phase 2b
TEAM FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Atlassian Corporation Investors to Secure Counsel Before Important April 4 Deadline in Securities Class Action - TEAM
Published: 2023-03-30 (Crawled : 23:00) - prnewswire.com
RAD | $0.6483 -5.58% 2.4M
|
Retail Trade
|
| O: -0.46%
H: 4.65%
C: 4.19%
TEAM S | $199.385 2.63% 2.57% 950K
|
Technology Services
|
| O: 0.73%
H: 6.23%
C: 5.82%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.03%
H: 0.4%
C: 0.13%
corporation deadline global
Vitiligo Therapeutics Market - Information on Key Vendors Including (Alkem Laboratories Ltd., Bausch Health Companies Inc., Canixa Life Sciences, and more)
Published: 2022-08-25 (Crawled : 11:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: 1.55%
H: 0.1%
C: 0.1%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: 1.04%
H: 0.62%
C: 0.34%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: 0.0%
H: 0.49%
C: 0.1%
BAX | $41.02 1.54% 0.0% 2.6M
|
Health Technology
|
| O: 0.55%
H: 1.56%
C: 1.51%
BHC | $8.53 0.95% 0.0% 4M
|
Health Technology
|
| O: 0.95%
H: 6.02%
C: 3.95%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.62%
H: 0.57%
C: 0.4%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.62%
H: 0.02%
C: -0.13%
companies health life therapeutics market
USD 8 Bn growth opportunity in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market | North America to emerge as key market | Technavio
Published: 2022-05-25 (Crawled : 04:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -1.42%
H: 2.73%
C: 2.73%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: -0.26%
H: 3.13%
C: 2.96%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
PBYI | $5.12 -0.97% -0.98% 290K
|
Health Technology
|
| O: -1.6%
H: 6.52%
C: 3.8%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.54%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 1.42%
H: 0.72%
C: 0.0%
america growth market her2- her2
Amgen To Present At The 39th Annual J.P. Morgan Healthcare Conference
Published: 2021-01-06 (Crawled : 00:00) - biospace.com/
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -1.21%
H: 3.79%
C: 3.67%
j.p. morgan healthcare conference
Immune-Onc Therapeutics Appoints Two New Members to its Board of Directors
Published: 2022-11-08 (Crawled : 15:20) - biospace.com/
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 2.0%
H: 4.99%
C: 3.48%
therapeutics
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 870K
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.